Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPulmonologyCentene Home Ventilators Coverage Update | OpenPay…
    Ask Trek AI about this page
    CurrentCentenePolicy CP.MP.184

    Home Ventilators

    Customize your policy alerts

    Sign up for Centene Policy CP.MP.184 alerts

    Get alerted when Policy CP.MP.184 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Medical necessity criteria for initial and continued use of noninvasive and invasive home ventilators for non‑Medicare Centene-affiliated plans; who qualifies and documentation/prior authorization expectations.

    Policy Summary
    PayerCentene
    PolicyHome Ventilators
    Policy CodePolicy CP.MP.184
    Change TypeMaterial coverage and operational language updates (initial certification clarifiedRAD/CPAP exclusions revisedbackup ventilator criteria added).
    Effective Date
    Next Review Date
    Key ActionObtain prior authorization for initial noninvasive ventilator use for a three-month period and document ongoing benefit and average use ≥4 hours/day for continued coverage.
    SourceLink
    POLICY UPDATE CHANGES

    Clarified initial request is for three months for noninvasive home ventilator use.

    Replaced BiPAP failure and contraindication criteria with requirement that member/enrollee could not be appropriately treated with a respiratory assist device (RAD) and that the device will not be used to provide RAD or CPAP therapy.

    Added criteria for second/back-up ventilator (noninvasive or invasive) for specific clinical or logistical reasons (e.g., different purposes, wheelchair use, remote residence).

    Added HCPCS code E0465 and included descriptions for E0465–E0468.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3 monthsinitial certification period
    >=4 hrs/24hminimum average daily use
    BMI >=30OHS BMI threshold
    PaCO2 >=45 mm HgPaCO2 threshold
    Non‑Medicare plansapplies to

    Coverage Criteria for Home Ventilators

    Initial Therapy — Restrictive/Neuromuscular

    Covered when ALL of the following are met for initial request (first 3 months):

    I.A Initial criteria (restrictive thoracic/neuromuscular): 1) Documentation of neuromuscular disease (e.g., amyotrophic lateral sclerosis) or a severe thoracic cage abnormality (e.g., post‑thoracoplasty, severe kyphoscoliosis); AND 2) one of the following obtained while the member/enrollee was stable (not in acute respiratory failure): an awake arterial blood gas PaCO2 >= 45 mm Hg measured on room air or prescribed oxygen; OR sleep oximetry demonstrating O2 saturation <88% for at least five minutes while breathing prescribed O2; OR if neuromuscular disease is present, maximal inspiratory pressure <= 60 cm H2O or forced vital capacity <= 50% predicted; AND 3) member/enrollee could not be appropriately treated with a respiratory assist device (RAD); AND 4) documentation that the noninvasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume‑assured pressure support).PaCO2 >= 45 mm Hg; MIP <= 60 cm H2O; FVC <= 50% predicted; sleep SpO2 <88% >=5 minutes

    Initial approval period is 3 months.

    Initial Therapy — Severe COPD

    Covered when ALL of the following are met for initial request (first 3 months):

    I.B Initial criteria (severe COPD): 1) An awake arterial blood gas PaCO2 >= 52 mm Hg measured at baseline while breathing baseline and prescribed FiO2 as specified; AND 2) CPAP/apnea treatment has been considered and ruled out (formal sleep testing not required if the medical record demonstrates sleep apnea is not the predominant cause of awake hypercapnia or nocturnal desaturation); AND 3) member/enrollee could not be appropriately treated with a respiratory assist device (RAD); AND 4) documentation that the noninvasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume‑assured pressure support).PaCO2 >= 52 mm Hg

    Initial approval period is 3 months.

    Initial Therapy — Obesity Hypoventilation Syndrome

    Covered when ALL of the following are met for initial request (first 3 months):

    I.C Initial criteria (obesity hypoventilation syndrome): 1) BMI >= 30; AND 2) an awake arterial blood gas PaCO2 >= 45 mm Hg measured at baseline while breathing prescribed FiO2; AND 3) sleep‑disordered hypoventilation documented by polysomnography and other conditions are not the primary cause of hypoventilation; AND 4) member/enrollee could not be appropriately treated with a respiratory assist device (RAD); AND 5) documentation that the noninvasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume‑assured pressure support).BMI >= 30; PaCO2 >= 45 mm Hg

    Initial approval period is 3 months. Polysomnography required to document hypoventilation.

    Continuation Therapy

    Covered when ALL of the following are met for continued use after initial three-month certification:

    II Continued use (noninvasive): 1) Documentation supports ongoing benefits from use of the device; AND 2) average use at least 4 hours per 24‑hour period; AND 3) the noninvasive home ventilator is not being used to provide RAD or CPAP therapy (i.e., will be used to provide average volume‑assured pressure support).>= 4 hours per 24-hour period

    Medical director review required for overlap syndromes (e.g., COPD plus sleep apnea).

    Invasive Ventilator Criteria

    Covered when ALL of the following are met:

    IV Invasive ventilator (initial and ongoing): Initial and ongoing use of an invasive ventilator is medically necessary for long‑term or chronic conditions or diseases affecting the ability to effectively maintain adequate respiratory status (examples: neuromuscular disease, thoracic restrictive disease, chronic respiratory failure following COPD), or when airway protection is required or noninvasive ventilation is contraindicated.

    Applies to non‑Medicare Centene‑affiliated plans; see corresponding Medicare policy for Medicare members.

    Backup Ventilator Coverage

    A second or back-up noninvasive or invasive ventilator is considered medically necessary for ANY of the following:

    V Second/back-up ventilator: A) A second ventilator serves a different purpose from the first based on medical needs (e.g., two different ventilator types required for different indications); OR B) the member/enrollee is confined to a wheelchair and requires a wheelchair‑mounted ventilator during the day and another ventilator for use while in bed; OR C) residence in remote areas with poor emergency access;

    Supportive documentation required to justify medical necessity for a second/back‑up ventilator.

    Use of a home ventilator solely to provide respiratory assist device (RAD) or CPAP therapy is excluded under the noninvasive ventilator coverage criteria. The device must be intended to provide ventilatory support (for example, average volume assured pressure support) and the documentation must explicitly state that the noninvasive home ventilator will not be used to provide RAD or CPAP therapy.

    Language authorizing ventilator coverage based on prior constructs such as ‘‘BiPAP failure’’ or other BiPAP treatment‑failure formulations has been removed. Requests must now document that the member/enrollee could not be appropriately treated with a respiratory assist device (RAD), and that the noninvasive home ventilator will not be used to provide RAD or CPAP therapy. BiPAP failure is no longer a standalone medical‑necessity criterion.

    Coding and Utilization Metrics

    Covered HCPCS codes referencedHCPCS
    E0465Home ventilator, any type, used with invasive interface (e.g., tracheostomy tube).
    E0466Home ventilator, any type, used with noninvasive interface (e.g., mask, chest shell).
    E0467Home ventilator, multi-function respiratory device, also performs functions of oxygen concentration, nebulization, aspiration, and cough stimulation; includes accessories.
    E0468Home ventilator; dual-function respiratory device, also performs additional function of cough stimulation; includes accessories.
    Average daily use — continued coverage
    Minimum average daily use>= 4 hours per 24-hour period
    BMI for Obesity Hypoventilation Syndrome (OHS)
    BMI threshold for OHS>= 30
    Arterial blood gas (PaCO2) thresholds
    PaCO2 threshold (general indications)>= 45 mm Hg
    PaCO2 threshold (severe COPD initial criteria)>= 52 mm Hg

    Provider Requirements and Prior Authorization

    Prior Authorization

    Prior Authorization Required — Timeframe & Continued-Use

    Prior authorization is required for initial requests and is issued for the first three months of noninvasive home ventilator (NIV) use. Continued authorization beyond the initial three-month period requires documentation demonstrating ongoing benefit and continued medical necessity.

    • Initial authorization period: 3 months
    • Continuation requires documentation of ongoing benefit and at-home use (see documentation callout)
    Documentation Required

    Required Clinical Documentation

    Submit clinical documentation with every prior authorization request. For initial requests include: diagnosis (e.g., neuromuscular disease, severe thoracic cage abnormality, obesity hypoventilation syndrome, severe COPD), relevant objective testing performed while the member was stable (not in acute respiratory failure), and evidence that a respiratory assist device (RAD) or CPAP would not appropriately treat the member when applicable.

    Clinical Background

    Respiratory failure may reflect impaired ventilatory (CO2 retention) or oxygenation (hypoxemia) function and can be acute or chronic. Noninvasive ventilation (NIV) delivers positive pressure via noninvasive interfaces (masks, nasal pillows, etc.) to support ventilation in selected acute and chronic respiratory failures and in the home setting can improve symptoms, quality of life, and reduce readmission and mortality. In contrast, invasive ventilation uses an invasive airway (eg, tracheostomy) when airway protection or ventilatory requirements exceed what can be provided noninvasively. The policy requires objective documentation of respiratory impairment (examples include awake PaCO2 ≥ 45 mm Hg for some indications, sleep oximetry with SpO2 <88% for ≥5 minutes, or physiologic measures such as maximal inspiratory pressure or FVC for neuromuscular disease) to support use of a home ventilator.

    Definitions

    Noninvasive ventilation (NIV) — definition and interfaces
    DefinitionAdministration of positive pressure to the lungs via noninvasive interfaces such as masks, nasal pillows, or helmets.
    Common interfacesOronasal mask, nasal mask, nasal prongs, full-face mask, mouthpieces, nasal pillows, helmets.
    Invasive ventilation — definition and invasive interfaces
    DefinitionAdministration of positive pressure to the lungs through an invasive interface such as a tracheostomy tube or endotracheal tube.
    Common invasive interfacesTracheostomy tube, endotracheal tube.
    Policy Summary
    PayerCentene
    PolicyHome Ventilators
    Policy CodePolicy CP.MP.184
    Change TypeMaterial coverage and operational language updates (initial certification clarifiedRAD/CPAP exclusions revisedbackup ventilator criteria added).
    Effective Date
    Next Review Date
    Key ActionObtain prior authorization for initial noninvasive ventilator use for a three-month period and document ongoing benefit and average use ≥4 hours/day for continued coverage.
    SourceLink
    On This Page
    Coverage Criteria for Home VentilatorsCoding and Utilization MetricsProvider Requirements and Prior AuthorizationClinical BackgroundDefinitions
    • Arterial blood gas showing PaCO2 ≥ threshold specified in policy for the indication (measured while awake and breathing at baseline or on prescribed O2 as applicable)
    • Sleep oximetry showing O2 saturation < 88% for ≥ 5 minutes when required by indication
    • Polysomnography documenting sleep-disordered hypoventilation when required (e.g., OHS)
    • Documented maximal inspiratory pressure or forced vital capacity when neuromuscular disease is present
    • For COPD: baseline awake PaCO2 per policy thresholds
    • Documentation that NIV will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume assured pressure support)
    • For continuation requests: evidence device is used ≥ average 4 hours per 24-hour period and member shows ongoing benefit from therapy
    Denial Risk

    CPAP/RAD Consideration and Exclusion

    Prior to initiating NIV, CPAP (or another RAD) must be considered and ruled out when clinically appropriate. If the record does not demonstrate that RAD/CPAP would be insufficient, the request may be denied. Formal testing for CPAP/RAD is not required only when documentation clearly shows sleep apnea is not the predominant cause of the member’s hypoventilation or nocturnal desaturation.

    • Record the consideration and ruling out of CPAP/RAD; if CPAP/RAD was trialed, provide results
    • If no formal testing, document clinical rationale showing OSA/CSA is not the primary driver of hypercapnia or desaturation